MFOLFOXIRI
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for MFOLFOXIRI, covering 2019-11-20 to 2026-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Bevacizumab Plus mFOLFOXIRI as First-line Treatment for Patients With Unresectable Metastatic Colorectal Cancer [Phase 3]